Understanding Fever Newborns Definition Causes Symptoms Management

Published

Table of Contents

Fever in newborns represents a critical clinical challenge due to their underdeveloped immune systems and heightened vulnerability to severe infections. Unlike older infants, whose physiological responses to illness are more predictable, newborns often exhibit subtle or non-specific signs that mask serious underlying conditions. This discrepancy underscores the necessity for precise temperature assessment, prompt diagnostic evaluation, and evidence-based intervention to mitigate risks such as sepsis, meningitis, or systemic inflammatory response syndrome (SIRS). The hypothalamus, though immature in neonates, plays a pivotal role in thermoregulation, responding to pyrogenic stimuli—whether bacterial endotoxins, viral antigens, or metabolic disturbances—by elevating core temperature as part of the innate immune defense. However, this adaptive mechanism can rapidly escalate into a medical emergency when left unchecked, particularly in the first 28 days of life, where mortality rates for untreated bacterial infections exceed 20%.

Clinical guidelines distinguish fever in newborns based on measurement modality (rectal temperatures ≥38.0°C or axillary ≥37.5°C) and age-specific thresholds, reflecting the unique thermoregulatory instability of this population. While environmental factors like overheating or dehydration may trigger transient elevations, infectious etiologies—ranging from urinary tract infections to congenital TORCH syndromes—demand rigorous exclusion. The diagnostic approach integrates risk stratification tools, such as the ROSE score, to determine the urgency of lumbar puncture, blood cultures, or empirical antibiotics, balancing the need for intervention against the risks of overutilization. This paradigm shift from empirical treatment to stratified care has reduced unnecessary hospitalizations while improving outcomes for low-risk infants managed outpatient.

what is fever in a newborn

Medical Definition and Physiological Basis of Fever in Newborns

Fever in newborns represents a critical physiological response to infection, inflammation, or other systemic stressors, distinguished by its unique clinical implications due to the immature immune and thermoregulatory systems of this age group. Unlike older infants, newborns (defined as infants aged 0–28 days) exhibit heightened vulnerability to febrile illnesses, as their hypothalamic set-point for temperature regulation remains less stable, and their immune responses are still developing. Fever in this population is not merely a symptom but a potential indicator of serious underlying conditions, including bacterial sepsis, meningitis, or urinary tract infections (UTIs), necessitating precise diagnostic approaches.

The physiological mechanisms underlying fever in newborns involve a complex interplay between exogenous pyrogens (e.g., bacterial endotoxins or viral antigens) and endogenous pyrogens (primarily cytokines such as interleukin-1β [IL-1β], interleukin-6 [IL-6], and tumor necrosis factor-alpha [TNF-α]). These cytokines act on the hypothalamus, particularly the preoptic area, to elevate the thermoregulatory set-point. The subsequent release of prostaglandin E2 (PGE₂) from hypothalamic neurons further amplifies this response, leading to vasoconstriction, increased heat production (via shivering or non-shivering thermogenesis), and reduced heat dissipation (e.g., peripheral vasoconstriction). In newborns, this process is compounded by their limited ability to mount a robust febrile response, often resulting in hypothermia or suboptimal fever in severe infections—a phenomenon known as "fever blunting" or "fever attenuation."

Physiological Mechanisms and Immune Response in Newborn Fever

The immune response in newborns differs significantly from that in older infants due to developmental immaturity in both innate and adaptive immunity. Key components of this response include:
Primary mediators of fever in newborns:
  • Exogenous pyrogens: Bacterial lipopolysaccharides (LPS), viral proteins, or fungal antigens.
  • Endogenous pyrogens: Cytokines (IL-1β, IL-6, TNF-α) released by macrophages, neutrophils, and dendritic cells in response to infection.
  • Prostaglandin E₂ (PGE₂): Synthesized in the hypothalamus via the cyclooxygenase (COX) pathway, PGE₂ acts on thermosensitive neurons to reset the hypothalamic set-point upward.
    • The hypothalamic response to pyrogens involves three phases:
    1. Affector phase: Pyrogens trigger cytokine release, which signals the hypothalamus.
    2. Transduction phase: Cytokines activate COX enzymes, leading to PGE₂ production.
    3. Effector phase: PGE₂ binds to EP₃ receptors on hypothalamic neurons, initiating thermoregulatory adjustments (e.g., increased metabolic rate, vasoconstriction).

    In newborns, the immature hypothalamic-pituitary-adrenal (HPA) axis may impair the febrile response, particularly in preterm infants or those with congenital infections. Additionally, the reduced production of anti-inflammatory cytokines (e.g., IL-10) further predisposes newborns to prolonged or atypical febrile episodes.

    Normal Temperature Ranges and Fever Definition in Newborns

    Temperature regulation in newborns is highly variable due to their large surface area-to-body mass ratio, limited subcutaneous fat, and immature autonomic control. Normal temperature ranges for newborns (0–28 days) vary by measurement site and environmental conditions:
    Clinical guidelines for fever in newborns (0–28 days):
  • Rectal temperature ≥ 38.0°C (100.4°F) is universally accepted as febrile in this age group.
  • Axillary temperature ≥ 37.5°C (99.5°F) may indicate fever but requires rectal confirmation due to lower accuracy.
  • Tympanic temperature ≥ 38.0°C (100.4°F) is reliable but less commonly used due to technical challenges.
  • Hypothermia (rectal temperature < 36.5°C [97.7°F]) in a newborn with signs of infection is an emergency, as it may indicate severe illness (e.g., sepsis, congenital infections).
    • Environmental factors significantly influence temperature readings:
  • Axillary measurements are often lower than rectal readings by 0.3–0.5°C and are influenced by ambient temperature and clothing.
  • Temporal artery thermometry may overestimate or underestimate rectal temperatures by up to 0.5°C in newborns.
  • Core temperature (rectal or esophageal) is the gold standard for accuracy but is rarely used in clinical practice due to discomfort and risk of perforation.

    • Comparison of Fever in Newborns vs. Older Infants/Children

    The presentation, underlying causes, and clinical urgency of fever differ markedly between newborns and older infants/children. Below is a comparative analysis based on symptomatology, etiology, and management priorities:
    Feature Newborns (0–28 days) Older Infants/Children (>28 days)
    Definition of Fever Rectal ≥ 38.0°C (100.4°F); axillary ≥ 37.5°C (99.5°F) with confirmation. Rectal/axillary ≥ 38.0°C (100.4°F); tympanic ≥ 38.3°C (101°F).
    Common Causes
    • Bacterial infections (sepsis, meningitis, UTI, pneumonia).
    • Congenital infections (TORCH: Toxoplasma, Other, Rubella, CMV, HSV).
    • Invasive procedures (e.g., circumcision, catheterization).
    • Metabolic disorders (e.g., adrenal hemorrhage, hypothyroidism).
    • Viral infections (RSV, influenza, gastroenteritis).
    • Bacterial infections (otitis media, sinusitis, cellulitis).
    • Vaccine reactions (e.g., DTaP, MMR).
    • Environmental factors (overheating, dehydration).
    Associated Symptoms
    • Poor feeding, lethargy, or irritability.
    • Hypothermia or temperature instability.
    • Respiratory distress (grunting, apnea).
    • Jaundice, petechiae, or bulging fontanelle (signs of meningitis).
    • Fussiness, diarrhea, or rash.
    • Localized pain (e.g., ear tugging, abdominal distension).
    • Fever duration > 48 hours may indicate bacterial focus.
    Urgency Level
    • Emergency: Fever with lethargy, poor perfusion, or hypothermia.
    • High-risk: Fever without source (FWS) requires full sepsis workup (lumbar puncture, blood cultures, urine analysis).
    • Hospitalization recommended for all febrile newborns until bacterial infection is ruled out.
    • Low-risk: Well-appearing child with fever < 39°C (102.2°F) and no focal signs.
    • Moderate-risk: Fever > 39°C (102.2°F) or focal symptoms (e.g., otitis media).
    • High-risk: Toxic appearance, fever > 40°C (104°F), or immunocompromised status.
    Diagnostic Workup
    • Complete blood count (CBC) with differential.
    • Blood culture, urine culture, cerebrospinal fluid (CSF) analysis.
    • Chest X-ray if respiratory symptoms present.

      • Common Causes and Triggers of Fever in Newborns

      Fever in newborns is often a clinical manifestation of underlying pathological processes, with infectious and non-infectious etiologies requiring prompt differentiation due to their distinct management strategies. While neonates possess immature immune responses, their febrile presentations are frequently linked to systemic infections, metabolic disturbances, or environmental stressors. Understanding the predominant causative agents—classified by microbial origin and anatomical involvement—alongside non-infectious triggers, is essential for early diagnosis and intervention. This section categorizes the most frequent infectious causes, non-infectious mechanisms, and maternal-derived pathologies, while highlighting red-flag symptoms that necessitate urgent medical evaluation.

      Infectious Causes of Fever in Newborns by Microbial Origin and Organ System

      Infectious agents account for the majority of febrile episodes in neonates, with bacterial pathogens posing the highest risk for severe morbidity and mortality due to their propensity for invasive disease. Viral infections, though often self-limited, may also present with fever and systemic symptoms, while fungal infections remain a critical concern in premature or immunocompromised infants. The following categorization emphasizes the most clinically significant pathogens, their associated organ systems, and the epidemiological context influencing their prevalence.

      ### Bacterial Infections
      Bacterial infections in newborns frequently involve the bloodstream (sepsis), central nervous system (meningitis), respiratory tract (pneumonia), urinary tract (UTI), and skin/soft tissues. Early-onset sepsis (EOS), occurring within 72 hours of birth, is typically acquired vertically during delivery and is dominated by Group B Streptococcus (GBS), Escherichia coli, and other Gram-negative enteric organisms. Late-onset sepsis (LOS), emerging after 72 hours, reflects hospital-acquired or community-acquired infections, with Staphylococcus aureus (including methicillin-resistant strains), Streptococcus pneumoniae, and Klebsiella spp. as common pathogens.

      Key bacterial syndromes and their typical presentations:

    • Early-onset sepsis (EOS):
    • Pathogens: GBS, E. coli, Listeria monocytogenes, Haemophilus influenzae.
    • Transmission: Vertical (intrapartum or ascending infection).
    • Clinical features: Respiratory distress, poor perfusion, hypothermia (or fever), lethargy, or seizures.
    • Risk factors: Prolonged rupture of membranes (>18 hours), maternal fever/chorioamnionitis, preterm birth.

      • - Late-onset sepsis (LOS):

    • Pathogens: S. aureus (including MRSA), Coagulase-negative staphylococci (CONS), Pseudomonas aeruginosa, Enterococcus spp.
    • Transmission: Nosocomial (indwelling catheters, ventilators) or community-acquired.
    • Clinical features: Fever (or hypothermia), irritability, poor feeding, apnea, or focal infections (e.g., osteomyelitis, cellulitis).

      • - Meningitis:

    • Pathogens: GBS, E. coli, Listeria monocytogenes, S. pneumoniae.
    • Distinguishing features: Bulging fontanelle, seizures, altered consciousness, or focal neurological deficits.
    • Complications: Hydrocephalus, hearing loss, developmental delays.

      • - Urinary Tract Infections (UTIs):

    • Pathogens: E. coli (>50% of cases), Klebsiella spp., Enterobacter spp., Proteus mirabilis.
    • Risk factors: Vesicoureteral reflux, congenital anomalies (e.g., posterior urethral valves).
    • Clinical features: Fever, poor feeding, vomiting, or sepsis-like syndrome; asymptomatic bacteriuria is rare in neonates.

      • - Pneumonia:

    • Pathogens: GBS, Chlamydia trachomatis (in neonates <4 weeks), Ureaplasma urealyticum, S. aureus.
    • Transmission: Vertical (ascending infection) or horizontal (nosocomial).
    • Clinical features: Tachypnea, grunting, retractions, hypoxia, or apnea.

      • ### Viral Infections
      Viral febrile illnesses in neonates are typically less severe than bacterial infections but may still result in systemic involvement. Herpes simplex virus (HSV), enteroviruses, and respiratory syncytial virus (RSV) are among the most clinically significant. Congenital viral infections (e.g., CMV, HSV, rubella) may present with fever, hepatosplenomegaly, or neurological symptoms shortly after birth.

      Notable viral pathogens and their manifestations:

    • Herpes Simplex Virus (HSV):
    • Transmission: Vertical (intrapartum exposure to HSV-2).
    • Clinical forms:
    • Skin/eye/mouth (SEM) disease: Vesicular rash, keratoconjunctivitis.
    • Disseminated disease: Fever, hepatosplenomegaly, coagulopathy, seizures.
    • CNS involvement: Encephalitis, meningitis.
    • Diagnosis: PCR from CSF, blood, or lesion swabs.

      • - Enteroviruses (e.g., Coxsackievirus, Echovirus):

    • Transmission: Fecal-oral or respiratory droplets.
    • Clinical features: Fever, irritability, rash (maculopapular), meningitis, or sepsis-like syndrome.
    • Seasonality: Peaks in summer/fall.

      • - Respiratory Syncytial Virus (RSV) and Parainfluenza:

    • Clinical features: Fever, wheezing, apnea (in premature infants), or bronchiolitis.
    • High-risk groups: Preterm infants, congenital heart disease.

      • - Cytomegalovirus (CMV):

    • Transmission: Congenital (intrauterine) or postnatal (breast milk, saliva).
    • Clinical features: Hepatosplenomegaly, jaundice, thrombocytopenia, or sensorineural hearing loss.

      • ### Fungal Infections
      Fungal infections in newborns are associated with high mortality rates, particularly in preterm infants, those with indwelling catheters, or prolonged antibiotic use. Candida albicans and Candida parapsilosis are the most common pathogens, often leading to candidemia, meningitis, or disseminated disease.

      Risk factors and clinical features:

    • Candidiasis:
    • Risk factors: Low birth weight, central venous catheters, broad-spectrum antibiotics, neonatal intensive care unit (NICU) stay.
    • Clinical manifestations:
    • Localized: Oral thrush (white plaques on mucosa), diaper rash.
    • Systemic: Fever, lethargy, respiratory distress, hepatosplenomegaly, or shock.
    • Diagnosis: Blood cultures, CSF PCR, or urine antigen tests.

      • Non-Infectious Triggers of Fever in Newborns

      Non-infectious causes of fever in newborns are often overlooked but may present diagnostic challenges due to overlapping symptoms with infectious etiologies. These triggers include environmental factors, metabolic disorders, vaccinations, and iatrogenic causes. Recognizing these mechanisms is critical to avoid unnecessary antibiotic use and ensure appropriate management.

      ### Environmental and Physiological Causes
      Newborns are highly susceptible to thermal dysregulation due to immature hypothalamic temperature regulation and a high surface-area-to-body-mass ratio. Overheating, dehydration, and excessive clothing can lead to non-infectious hyperthermia, which may mimic febrile illness.

      Key environmental triggers:

    • Overheating:
    • Mechanism: Excessive swaddling, high ambient temperature, or improper incubator settings.
    • Clinical features: Flushed skin, sweating, tachypnea, or lethargy.
    • Risk factors: Prematurity, low birth weight, or environmental neglect.

      • - Dehydration:

    • Mechanism: Inadequate fluid intake (e.g., poor breastfeeding technique, diarrhea, or vomiting).
    • Clinical features: Dry mucous membranes, sunken fontanelle, oliguria, or tachycardia.
    • Complication: Hypernatremic dehydration, which may present with fever due to altered thermoregulation.

      • - Transient Tachypnea of the Newborn (TTN):

    • Mechanism: Delayed clearance of fetal lung fluid, leading to mild respiratory distress.
    • Associated fever: Low-grade fever may occur due to increased metabolic demand or subclinical inflammation.
    • Resolution: Typically self-limited within 24–72 hours.

      • ### Metabolic and Endocrine Disorders
      Metabolic disturbances can disrupt cellular energy production, leading to fever via pyrogenic cytokine release or altered thermoregulation. These conditions often present with poor feeding, lethargy, or seizures, necessitating metabolic workups.

      Common metabolic causes of fever:

    • Inborn Errors of Metabolism (IEM):
    • Organic acidemias (e.g., propionic acidemia, methylmalonic acidemia

      • what is fever in a newborn - Ilustrasi 2

      Symptoms, Signs, and Clinical Presentation of Fever in Newborns

      Fever in newborns presents unique diagnostic challenges due to their limited ability to mount a robust immune response and their physiological instability. Unlike older infants, febrile newborns often exhibit non-specific symptoms that may overlap with serious bacterial infections (SBIs), necessitating meticulous clinical assessment. The clinical presentation varies significantly between term and preterm infants, with preterm newborns demonstrating heightened vulnerability to complications. Accurate vital sign measurement and recognition of subtle signs are critical for timely intervention.

      Non-Specific Symptoms and Clinical Differences from Older Infants

      Newborns lack the ability to verbalize discomfort, making their symptoms rely heavily on behavioral and physical cues. Key non-specific manifestations of fever in newborns include:

      - Irritability or lethargy: Excessive crying, high-pitched or weak vocalizations, or unusual quietness may indicate systemic distress.

    • Altered feeding patterns: Poor suckling, refusal to feed, or vomiting suggest gastrointestinal or metabolic involvement.
    • Changes in skin color: Pallor, mottling, cyanosis, or jaundice progression may signal hypoxia, sepsis, or liver dysfunction.
    • Respiratory abnormalities: Tachypnea, grunting, or apnea warrant immediate evaluation for respiratory infections or sepsis.
    • Hypothermia or hyperthermia: Newborns may present with fever or hypothermia (temperature <36.5°C), particularly in preterm or ill infants, due to impaired thermoregulation.

      • In contrast, older infants typically exhibit more localized symptoms (e.g., otitis media, urinary tract infection) and may demonstrate fever as a more pronounced symptom. Newborns, however, often lack these specific signs, requiring clinicians to rely on vital sign abnormalities, laboratory markers, and physical examination findings to guide diagnosis.

      Step-by-Step Guide to Assessing Vital Signs in Febrile Newborns

      Accurate vital sign measurement is foundational in evaluating febrile newborns, as deviations from normal ranges may indicate serious pathology. The following structured approach ensures consistency and reliability:

      1. Temperature Measurement

    • Method: Electronic thermometers (rectal or axillary) are preferred for precision. Tympanic thermometers are less reliable in newborns due to ear canal size and cerumen obstruction.
    • Normal Range: Rectal temperature 36.5–37.5°C (97.7–99.5°F); axillary 36.0–37.0°C (96.8–98.6°F).
    • Abnormal Findings: Rectal temperature ≥38.0°C (100.4°F) or ≤36.0°C (96.8°F) warrants further investigation. Note: Fever in the first 28 days of life is defined as ≥38.0°C rectally, regardless of gestational age.

      • 2. Heart Rate Assessment

    • Method: Auscultation with a stethoscope or pulse oximetry for continuous monitoring.
    • Normal Range:
    • Term newborns: 100–160 beats/min (bradycardia <100, tachycardia >160).
    • Preterm newborns: 120–180 beats/min (bradycardia <120, tachycardia >180).
    • Abnormal Findings: Persistent tachycardia (>180 beats/min) or bradycardia (<80 beats/min) may indicate sepsis, dehydration, or cardiac compromise.

      • 3. Respiratory Rate Evaluation

    • Method: Count breaths for 60 seconds while observing chest wall movement.
    • Normal Range:
    • Term newborns: 30–60 breaths/min (tachypnea >60).
    • Preterm newborns: 40–70 breaths/min (tachypnea >70).
    • Abnormal Findings: Grunting, nasal flaring, or retractions suggest respiratory distress, while apnea (cessation of breathing >20 seconds) is an emergency requiring resuscitation.

      • 4. Blood Pressure Monitoring

    • Method: Oscillometric or Doppler devices; cuff size must match limb circumference.
    • Normal Range: Systolic BP ≥60 mmHg (adjusted for gestational age and postnatal age).
    • Abnormal Findings: Hypotension (<60 mmHg in term, <50 mmHg in preterm) indicates shock or sepsis.

      • Tools and Techniques:

    • Electronic thermometers (e.g., Welch Allyn SureTemp) provide rapid, accurate readings with minimal discomfort.
    • Skin probes (e.g., neonatal skin temperature monitors) are useful in NICU settings for continuous monitoring.
    • Pulse oximetry (e.g., Masimo Rad-87) allows simultaneous assessment of heart rate and oxygen saturation.

      • Critical Consideration: Vital signs should be measured serially (every 1–2 hours in unstable infants) and correlated with clinical examination findings. Hypothermia in a febrile newborn is an ominous sign, often associated with sepsis or adrenal insufficiency.

      Clinical Features of Serious Bacterial Infections in Febrile Newborns

      Serious bacterial infections (SBIs), including sepsis, meningitis, and pneumonia, account for significant morbidity and mortality in febrile newborns. Early recognition is paramount, as delays in treatment (>4 hours) increase mortality rates. The following features, while non-specific, should heighten clinical suspicion:
      Key Clinical Red Flags for SBIs in Febrile Newborns
    • Systemic Toxicity: Lethargy, poor perfusion (capillary refill >3 seconds), or mottling.
    • Respiratory Distress: Tachypnea (>60 breaths/min in term, >70 in preterm), grunting, or apnea.
    • Neurological Signs: Bulging fontanelle, seizures, or hypotonia (suggestive of meningitis or encephalopathy).
    • Gastrointestinal Symptoms: Bilious emesis, abdominal distension, or bloody stools (indicative of necrotizing enterocolitis or sepsis).
    • Laboratory Abnormalities:
    • Complete Blood Count (CBC): Leukopenia (<5,000/µL), left shift (bandemia >1,500/µL), or thrombocytopenia (<150,000/µL).
    • C-Reactive Protein (CRP): Elevated (>10 mg/L) suggests bacterial infection (though sensitivity is low in early sepsis).
    • Blood Culture: Positive in ~20–30% of febrile newborns with SBIs; Staphylococcus aureus, Streptococcus agalactiae (GBS), and Escherichia coli are common pathogens.
    • Lumbar Puncture Findings: CSF pleocytosis (>20 white blood cells/µL), hypoglycorrhachia (CSF glucose <40% of serum), or elevated protein (>150 mg/dL) supports meningitis.
      • Pathophysiological Insight: Newborns mount a blunted inflammatory response compared to older children, leading to atypical presentations. For example, fever may be absent in up to 30% of newborns with sepsis, particularly in preterm infants or those with overwhelming infection.

      Comparative Presentation of Fever in Term vs. Preterm Newborns

      The clinical presentation of fever differs markedly between term and preterm newborns due to gestational age-related vulnerabilities, including immature immune systems and thermoregulatory instability.

      Term Newborns (≥37 weeks gestation)

    • Immune Response: Mature humoral and cellular immunity, though still susceptible to vertical transmission of pathogens (e.g., GBS, E. coli).
    • Fever Presentation: More likely to exhibit classic fever (≥38.0°C) with localized signs (e.g., irritability, poor feeding).
    • Common Causes: Urinary tract infections (UTIs), respiratory infections, or sepsis from maternal flora.
    • Prognosis: Better overall outcomes with timely antibiotic therapy, though complications (e.g., meningitis) carry high morbidity.

      • Preterm Newborns (<37 weeks gestation)

    • Immune Deficiencies:
    • Neutrophil dysfunction: Impaired chemotaxis and phagocytosis increase susceptibility to infections.
    • Complement system immaturity: Reduced opsonization and bacterial clearance.
    • Passive immunity deficits: Lower maternal IgG transfer in very preterm infants (<32 weeks).
    • Thermoregulatory Instability:
    • Poor brown fat reserves: Preterm infants lack sufficient subcutaneous fat, leading to hypothermia or hyperthermia with minimal environmental changes.
    • Evaporative heat loss: Thin skin and large surface-area-to-body-weight ratio exacerbate temperature fluctuations.
    • Fever Presentation:
    • Atypical fever patterns: Fever may be intermittent or absent, with hypothermia being a more reliable indicator of sepsis.
    • Non-specific signs: Apnea, bradycardia, or sudden desaturation may precede overt fever.
    • Pathogen Vulnerabilities:
    • Nosocomial infections: *Coagulase-negative staphylococ

      • Diagnostic Approaches and When to Seek Emergency Care in Febrile Newborns

      The evaluation of a febrile newborn requires a systematic and time-sensitive approach to differentiate between benign self-limiting causes and serious bacterial infections (SBIs), which carry high morbidity and mortality risks. Diagnostic decisions are guided by clinical risk stratification, age-specific thresholds, and the presence of comorbidities. Healthcare providers must balance the need for thorough assessment with the potential for delayed treatment in critically ill infants. This section outlines the structured diagnostic workflow, including history-taking, physical examination, laboratory investigations, and imaging studies, while emphasizing the criteria for lumbar puncture and emergency care triggers.

      Stepwise Diagnostic Evaluation in Febrile Newborns

      The diagnostic process begins with a detailed history-taking and physical examination, followed by targeted laboratory tests to assess for SBIs. The approach varies based on the infant’s age, gestational history, and clinical stability.

      History-Taking
      A focused maternal and neonatal history includes:

    • Maternal factors: Prolonged rupture of membranes (>18 hours), chorioamnionitis, group B Streptococcus (GBS) colonization status, or maternal fever during labor.
    • Neonatal factors: Gestational age at birth, postnatal age (days of life), feeding difficulties, vomiting, diarrhea, or lethargy.
    • Environmental exposures: Daycare attendance, recent hospitalizations, or contact with infectious individuals.

      • Physical Examination
      The assessment prioritizes signs of sepsis, meningitis, or focal infections:

    • Vital signs: Tachycardia, tachypnea, or hypotension indicate systemic illness.
    • Skin: Petechiae, jaundice, or rashes may suggest meningococcemia or disseminated infection.
    • Neurological status: Irritability, poor feeding, or bulging fontanelle raise suspicion for meningitis.
    • Abdominal examination: Distension or tenderness may indicate urinary tract infection (UTI) or intra-abdominal sepsis.

      • Initial Laboratory Investigations
      Laboratory tests are selected based on clinical suspicion and age-specific risk. Core investigations include:

    • Complete Blood Count (CBC): Elevated or low white blood cell count (WBC), left shift (immature neutrophils), or thrombocytopenia may indicate bacterial infection.
    • Blood cultures: Essential for identifying bacteremia; sensitivity decreases with antibiotic pre-treatment.
    • Cerebrospinal fluid (CSF) analysis: Required in high-risk infants to diagnose meningitis (see Lumbar Puncture Criteria below).
    • Urinalysis and urine culture: Obtained via catheterization or suprapubic aspiration to detect UTI, a common source of fever in newborns.
    • C-reactive protein (CRP) and procalcitonin: Elevated levels support bacterial infection but lack specificity for immediate management decisions.
    • Blood glucose: Hypoglycemia may accompany sepsis or metabolic disorders.

      • Lumbar Puncture Criteria in Febrile Newborns

      Lumbar puncture (LP) is a critical diagnostic procedure to rule out bacterial meningitis, but its indication depends on age, clinical risk factors, and local guidelines. The following criteria are widely adopted:

      Age-Specific Thresholds

    • <28 days of life: LP is performed in all febrile infants unless contraindicated, as the risk of meningitis is highest in this group.
    • 29–60 days of life: LP is indicated if:
    • The infant appears toxic (poor perfusion, altered mental status, or respiratory distress).
    • There are no clear alternative explanations for fever (e.g., UTI with sterile CSF).
    • Local protocols recommend LP for infants with gestational age <37 weeks or WBC >20,000/mm³ with left shift.
    • >60 days of life: LP is selectively performed based on clinical suspicion (e.g., focal neurological signs, high-risk comorbidities).

      • Contraindications to Lumbar Puncture

    • Unstable hemodynamic status (e.g., shock, severe respiratory distress).
    • Coagulopathy (e.g., disseminated intravascular coagulation, thrombocytopenia <50,000/mm³).
    • Signs of increased intracranial pressure (e.g., bulging fontanelle, focal neurological deficits).
    • Skin infection or sepsis at the puncture site (risk of contamination).

      • CSF Analysis Interpretation

    • Bacterial meningitis: Elevated opening pressure, >1,000 WBC/mm³ (predominantly neutrophils), low glucose (<40% of serum glucose), and elevated protein (>150 mg/dL).
    • Viral meningitis: Lymphocytic pleocytosis (5–500 WBC/mm³), normal glucose, and mildly elevated protein.
    • False negatives: Up to 20% of infants with bacterial meningitis may have normal CSF initially; clinical correlation is essential.

      • Risk Stratification: Low-Risk vs. High-Risk Febrile Newborns

      Management decisions are guided by clinical risk stratification, which considers gestational age, postnatal age, comorbidities, and laboratory findings. The following table compares low-risk and high-risk infants, outlining key differentiating factors:
      Factor Low-Risk Febrile Newborn High-Risk Febrile Newborn
      Postnatal Age ≥29 days (term infants) or ≥48–72 hours (preterm infants). <28 days or ≥29–60 days with risk factors (e.g., gestational age <37 weeks, chronic lung disease).
      Gestational Age ≥37 weeks (full-term) with no comorbidities. <37 weeks, very low birth weight (<1,500 g), or congenital anomalies.
      Clinical Appearance Well-appearing, normal perfusion, no focal signs, feeding well. Toxic appearance (lethargy, poor perfusion, apnea, seizures), focal neurological deficits, or signs of shock.
      Laboratory Findings WBC 5,000–15,000/mm³ with normal differential, CRP/procalcitonin <20 mg/L. WBC >20,000/mm³ with left shift, thrombocytopenia, or abnormal CRP/procalcitonin.
      Urinalysis Sterile urine or asymptomatic bacteriuria (no fever recurrence). Positive urine culture with pyuria or clinical signs of UTI (e.g., poor feeding, vomiting).
      Management Approach Observation with close monitoring; selective antibiotics if UTI confirmed. Empiric broad-spectrum antibiotics (e.g., ampicillin + gentamicin or cefotaxime), LP, and possible hospitalization.
      Key Considerations for Low-Risk Infants
    • Observation protocols (e.g., "well-baby" rules) may apply if:
    • The infant is term (≥37 weeks), ≥29 days old, and well-appearing.
    • Urine culture is negative, and there is no evidence of bacteremia.
    • Follow-up: Parents receive clear instructions for fever recurrence (e.g., return if fever persists >24 hours or worsens).

      • Key Considerations for High-Risk Infants

    • Empiric antibiotics are initiated within 1 hour of presentation for suspected SBIs.
    • Hospitalization is mandatory for infants with:
    • Bacteremia, meningitis, or pneumonia.
    • Comorbidities (e.g., congenital heart disease, immunodeficiency).
    • Unreliable follow-up (e.g., lack of caregiver support).

      • Role of Imaging Studies in Febrile Newborns

      Imaging is selectively used in febrile newborns to identify focal infections or complications, but its role is limited by technical challenges (e.g., radiation exposure, poor tissue contrast) and the need for clinical correlation.

      Indications for Imaging
      1. Suspected Urinary Tract Infection

      what is fever in a newborn - Ilustrasi 3

      Management and Treatment Strategies for Fever in Newborns

      Fever in newborns requires prompt and structured intervention due to their heightened vulnerability to infections, dehydration, and systemic complications. Effective management involves a combination of immediate stabilization, targeted pharmacological therapy, and risk-stratified decision-making to determine the need for hospitalization. The approach must balance aggressive treatment of potential bacterial infections with supportive care to mitigate adverse outcomes, such as seizures, hypovolemia, or progression to sepsis.

      Therapeutic strategies are guided by the newborn’s gestational age, postnatal age, clinical stability, and underlying risk factors. Antipyretics are used judiciously, while antibiotics are reserved for high-risk infants or those with signs of serious bacterial infection (SBI). Hospital admission criteria are determined using validated risk stratification tools, such as the ROSE (Risk Stratification for Young Infants with Fever) score, which aids clinicians in identifying infants who require inpatient evaluation and treatment.

      Immediate Interventions and Supportive Care

      The initial management of a febrile newborn focuses on stabilizing vital signs, preventing complications, and ensuring adequate hydration. Cooling measures should be implemented cautiously to avoid iatrogenic hypothermia, particularly in preterm or low-birth-weight infants. Fluid resuscitation is critical in cases of suspected dehydration or shock, with isotonic fluids (e.g., 0.9% normal saline or lactated Ringer’s solution) administered at 20 mL/kg over 5–10 minutes if hypotension or poor perfusion is present.

      Monitoring parameters include:

    • Vital signs: Heart rate, respiratory rate, blood pressure, and oxygen saturation, with particular attention to tachycardia (>180 bpm) or bradycardia (<100 bpm), which may indicate sepsis or hypoxia.
    • Neurological status: Assessment for irritability, lethargy, or seizures, which warrant immediate anticonvulsant therapy (e.g., phenobarbital or lorazepam) and further evaluation for meningitis or metabolic derangements.
    • Hydration status: Skin turgor, capillary refill time (<2 seconds), and urine output (expected at 1–3 mL/kg/hour in the first week of life).

      • Parental education must emphasize:

    • Fever management at home: Use of antipyretics (e.g., acetaminophen) for comfort, with dosing adjusted for weight and age.
    • Signs of deterioration: Lethargy, poor feeding, apnea, or worsening fever, which mandate urgent medical evaluation.
    • Preventive measures: Hand hygiene, avoiding crowded settings, and completing vaccination schedules to reduce infection risk.

      • Antipyretic Therapy and Dosing Guidelines

      Antipyretics are administered to reduce fever-related discomfort and prevent complications such as seizures, though they do not address the underlying cause. Acetaminophen (paracetamol) is the preferred agent due to its safety profile and efficacy in newborns. Dosing guidelines are as follows:
      Acetaminophen Dosage for Newborns
    • Oral/Rectal: 10–15 mg/kg per dose, every 6 hours (maximum 60 mg/kg/day).
    • Intravenous: 10–15 mg/kg per dose, every 6 hours (diluted in compatible fluids).
    • Neonatal considerations:
    • Avoid in infants with glucose-6-phosphate dehydrogenase (G6PD) deficiency or hepatic impairment.
    • Rectal administration may be less reliable due to variable absorption.
    • Monitor for hepatotoxicity with prolonged use (>72 hours).
      • Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are contraindicated in newborns younger than 6 months due to risks of renal impairment, bleeding, and closure of the ductus arteriosus. Cooling measures (e.g., tepid sponge baths) should be limited to 15–30 minutes and avoided in hypotensive or hypothermic infants.

      Antibiotic Therapy for Suspected Bacterial Infections

      Empirical antibiotic therapy is initiated in febrile newborns with signs of SBI, such as tachypnea, lethargy, poor feeding, or hypothermia. The choice of antibiotics depends on the infant’s postnatal age and local bacterial resistance patterns. Ampicillin and gentamicin remain the first-line regimen for most febrile newborns, targeting common pathogens including Streptococcus agalactiae, Escherichia coli, and Listeria monocytogenes.
      Empirical Antibiotic Regimens for Febrile Newborns
      Postnatal AgeAntibiotic RegimenDuration
      0–28 daysAmpicillin (50 mg/kg IV q8h) + Gentamicin (2.5 mg/kg IV q24h)7–14 days (until culture results)
      29–60 daysCefotaxime (50 mg/kg IV q6–8h) or Ceftriaxone (50 mg/kg IV q24h) + Gentamicin (2.5 mg/kg IV q24h)3–5 days (if S. pneumoniae or N. meningitidis suspected)
      Preterm (<37 weeks)Ampicillin + Gentamicin (adjusted for renal function)7–10 days (longer if meningitis)
      Adjustments may include:
    • Addition of vancomycin if methicillin-resistant Staphylococcus aureus (MRSA) is suspected (e.g., in nosocomial infections or central line-associated sepsis).
    • Switch to oral antibiotics (e.g., amoxicillin-clavulanate) if the infant is clinically stable and cultures are negative after 48–72 hours.
    • Lumbar puncture is performed prior to antibiotic administration if meningitis is suspected, with ceftriaxone or cefotaxime continued for 10–14 days if cerebrospinal fluid (CSF) shows bacterial growth.

      • Risk Stratification and Decision-Making for Hospital Admission

      The decision to admit a febrile newborn to the hospital is based on clinical risk factors, laboratory findings, and validated risk stratification tools. The ROSE score (for infants 29–60 days old) and KMC (Kaiser Permanente) criteria (for infants <29 days old) help standardize management by identifying low-risk infants who may be safely managed as outpatients.
      ROSE Score Criteria (29–60 Days Old)
    • Total score ≥1 indicates low risk for SBI and may allow outpatient management with close follow-up.
    • Score ≥2 warrants hospitalization for further evaluation.
      • Components:
    • Temperature ≥39°C (102.2°F)
    • Ill appearance or poor feeding
    • History of urinary tract infection (UTI) or bacterial illness
    • Absence of a reliable caregiver
    • Prematurity (<37 weeks gestation)
      • Hospital admission is indicated for:
    • Infants <29 days old with fever ≥38°C (100.4°F) due to higher risk of early-onset sepsis (EOS).
    • Signs of shock or sepsis (e.g., hypotension, mottling, oliguria).
    • Positive blood or CSF cultures pending definitive results.
    • Unreliable caregivers or inability to ensure follow-up.

      • Outpatient management may be considered for:

    • Term infants 29–60 days old with ROSE score ≤1, no focal infection, and reliable caregivers.
    • Partial hospitalization (e.g., observation unit) for infants requiring intravenous antibiotics but without severe illness.

      • Supportive Care Measures and Complication Monitoring

      Supportive care in febrile newborns focuses on preventing secondary complications, such as dehydration, seizures, and metabolic derangements. Key interventions include:
      1. Hydration and Electrolyte Balance
      2. Oral rehydration is preferred for stable infants with mild dehydration (e.g., 20–40 mL/kg of oral rehydration solution over 4 hours).
      3. Intravenous fluids are required for moderate-to-severe dehydration (e.g., 10% deficit replacement over 24 hours + maintenance).
      4. Monitor electrolytes (sodium, potassium, glucose) every 6–12 hours, especially in infants with vomiting or diarrhea.
      5. Neurological and Respiratory Support
      6. Seizure prophylaxis may be considered in high-risk infants (e.g., those with hypoglycemia, hypocalcemia, or meningitis), though routine use is not recommended.
      7. Oxygen therapy is administered if hypoxemia (SpO₂ <90%) or respiratory distress

        Fever in newborns serves as both a physiological alarm and a diagnostic enigma, demanding a multidisciplinary approach that integrates clinical acumen, laboratory precision, and parental vigilance. The interplay between immature immune responses, delayed symptom presentation, and the rapid progression of sepsis underscores the critical window for intervention within the first 48 hours of fever onset. Advances in risk stratification—such as the ROSE score—have refined outpatient management for select low-risk infants, yet the gold standard remains early recognition of red-flag symptoms (e.g., lethargy, poor perfusion, or bulging fontanelle) that mandate immediate hospitalization. Beyond immediate care, educating caregivers on proper thermometry techniques, hydration strategies, and the appropriate use of antipyretics (e.g., acetaminophen dosing adjusted for weight) empowers families to act swiftly while awaiting medical evaluation. Ultimately, the management of febrile newborns epitomizes the intersection of pediatric critical care and preventive medicine, where timely diagnosis and tailored treatment can mean the difference between recovery and irreversible complications.

        8. FAQ

        What does it mean if a newborn has a fever when measured in the armpit?

        A fever in a newborn’s armpit is typically considered when the temperature reads 37.5°C (99.5°F) or higher, though some providers use 38°C (100.4°F) as the threshold for concern. Armpit readings are less accurate than rectal (the gold standard for infants under 3 months), so confirm with a rectal thermometer if possible. Always contact a doctor for temperatures in this range in babies under 3 months old.

        What temperature is considered a fever in a newborn?

        A fever in a newborn is generally 38°C (100.4°F) or higher when measured rectally (the most accurate method). For babies under 3 months, any fever warrants immediate medical evaluation, as their immune systems are underdeveloped and serious infections (like sepsis or meningitis) can progress rapidly. Oral or armpit readings may require slightly higher thresholds (e.g., 37.8°C/100°F) but should still prompt caution.

        What exactly is a fever in a baby?

        A fever in a baby is an elevated body temperature, usually 38°C (100.4°F) or above, indicating the body’s response to infection, inflammation, or other illnesses. In infants, fevers can signal serious conditions that require prompt attention, especially in those under 3 months old. Babies may also feel warm to the touch, have flushed skin, or seem unusually fussy or lethargic.

        What defines fever in a neonate (newborn)?

        In a neonate (typically the first 28 days of life), a fever is defined as a rectal temperature of 38°C (100.4°F) or higher. This age group is at high risk for life-threatening infections, so any fever must be evaluated by a doctor immediately. Neonates often can’t regulate temperature well, and their symptoms may be subtle (e.g., poor feeding, weakness, or breathing changes).

        What counts as a high fever in a newborn?

        A high fever in a newborn is usually 39°C (102.2°F) or above when measured rectally, but any fever over 38°C (100.4°F) in a baby under 3 months is considered an emergency. High fevers in newborns can quickly escalate to dangerous levels, increasing the risk of seizures, dehydration, or organ strain. Immediate medical care is critical to identify and treat the underlying cause.

        What are the common causes of fever in a newborn?

        Common causes include bacterial infections (like urinary tract infections, sepsis, or meningitis), viral infections (such as colds or roseola), dehydration, overbundling (too many clothes/blankets), or vaccine reactions. Newborns are also vulnerable to congenital issues or infections acquired during birth. Unlike older children, their immune systems are immature, so even minor infections can trigger high fevers.

        Leave a Comment

        Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.